Polycystic ovary syndrome - Searching for an animal model

被引:0
作者
Szukiewicz, D [1 ]
Uilenbroek, JTJ [1 ]
机构
[1] Med Univ Sch, Dept Gen & Expt Pathol, PL-00325 Warsaw, Poland
关键词
polycystic ovary syndrome; animal model;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
At present, the understanding of the pathogenesis of polycystic ovary syndrome (PCOS) has advanced significantly, and improvements have been made in the treatment of PCOS symptoms. These achievements are to some extent the result of studies on experimental animals. However, a fully convincing animal model for study of polycystic ovaries, or of PCOS as whole, has not been established. This review article discusses several rat models for PCOS. Characteristics with respect to ovarian morphology, serum levels of LH, FSH, estradiol and androgens have been described and similarities to PCOS in women are discussed. The large number of the animal models for PCOS is a result of difficulties in induction of all pathological conditions similar to those seen in human PCOs. Two important considerations should be made that concern the development of an animal model for PCOs. Firstly, what is the main purpose of the model: study of ovarian morphology in PCOs or study of human disorders? Secondly, there is no reason land probably even a possibility) for creation of an "universal" PCOS animal model. The multifactorial etiology of the syndrome justifies such a point. Depending on what PCOS-related disorder is investigated, the most suitable animal model should be used.
引用
收藏
页码:259 / 275
页数:17
相关论文
共 50 条
  • [31] Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models
    Roland, Alison V.
    Moenter, Suzanne M.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2014, 35 (04) : 494 - 511
  • [32] Leptin, polycystic ovaries and polycystic ovary syndrome
    Jacobs, HS
    Conway, GS
    HUMAN REPRODUCTION UPDATE, 1999, 5 (02) : 166 - 171
  • [33] The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome
    Seow, Kok-Min
    Ting, Ching-Heng
    Huang, Seng-Wong
    Ho, Low-Tone
    Juan, Chi-Chang
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 696 - 704
  • [34] Polycystic ovary syndrome and pregnancy
    Sir-Petermann, Teresa
    Ladron de Guevara, Amanda
    Claudia Villarroel, Ana
    Preisler, Jessica
    Echiburu, Barbara
    Recabarren, Sergio
    REVISTA MEDICA DE CHILE, 2012, 140 (07) : 919 - 925
  • [35] Kisspeptin and Polycystic Ovary Syndrome
    Tang, Rong
    Ding, Xiaohong
    Zhu, Jianghu
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [36] Polycystic ovary syndrome in adolescents
    Dabadghao, Preeti
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (03)
  • [37] Obesity and the polycystic ovary syndrome
    Gambineri, A
    Pelusi, C
    Vicennati, V
    Pagotto, U
    Pasquali, R
    INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) : 883 - 896
  • [38] Puberty and polycystic ovary syndrome
    Witchel, Selma Feldman
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 254 : 146 - 153
  • [39] Ethnicity in polycystic ovary syndrome
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2023, 26 (01) : 15 - 20
  • [40] Genetics of Polycystic Ovary Syndrome
    Prapas, N.
    Karkanaki, A.
    Prapas, I
    Kalogiannidis, I
    Katsikis, I
    Panidis, D.
    HIPPOKRATIA, 2009, 13 (04) : 216 - 223